Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-HF-X pilot crossover randomised clinical trial
Authors
Lucas S. Zier (ORCID: https://orcid.org/0000-0002-3879-5529)
Matthew S. Durstenfeld (ORCID: https://orcid.org/0000-0002-7612-3352)
Matthew D. Hickey (ORCID: https://orcid.org/0000-0001-8913-1602)
Starley B. Shade (ORCID: https://orcid.org/0000-0001-8172-4649)
Dhruv S. Kazi (ORCID: https://orcid.org/0000-0002-9510-2979)
Paul A. Heidenreich (ORCID: https://orcid.org/0000-0001-7730-8490)
Jonathan D. Davis (ORCID: https://orcid.org/0000-0003-2822-6776)
Center for AIDS Research, University of Washington
University of California, San Francisco
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
National Institute of Allergy and Infectious Diseases
National Center for Advancing Translational Sciences
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-HF-X pilot crossover randomised clinical trial
Lucas S. Zier, Matthew S. Durstenfeld, Matthew D. Hickey, Starley B. Shade et al.
Citations
3 citations
Journal
BMJ Open
Topics
Medication Adherence and Compliance
Field-Weighted Citation Impact (FWCI)
4.55
article
Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-HF-X pilot crossover randomised clinical trial
Lucas S. Zier, Matthew S. Durstenfeld, Matthew D. Hickey, Starley B. Shade, Dhruv S. Kazi, Paul A. Heidenreich, Jonathan D. Davis, Colette DeJong, C. Wang, Priscilla Y. Hsue, Wayne T. Steward, Mark D. Huffman, Noémie Moreau, Elise D. Riley, Janet R. Grochowski, Alexander T. Sandhu, Anubha Agarwal, Justin C. Chen
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(3)
Institutions
San Francisco General Hospital (US), Harvard University (US), University of California, Los Angeles (US), University of California, San Francisco (US), Washington University in St. Louis (US), VA Palo Alto Health Care System (US), University of California System (US), The George Institute for Global Health (AU), Global Solutions for Infectious Diseases (US), Deaconess Hospital (US), Stanford University (US)
Funders
Doris Duke Charitable Foundation, National Institutes of Health, Center for AIDS Research, University of Washington, University of California, San Francisco, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences